Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) — The “Global Market for Pain Management Drugs and Devices” report has been added to ResearchAndMarkets.com’s offering.
The global market for pain management drugs and devices is poised for substantial growth, with a projected value of approximately $109.9 billion by the end of 2028. This growth is driven by several key factors, including the rising prevalence of chronic and neurological disorders, a growing geriatric population, and technological advancements in the field. The market is expected to witness a compound annual growth rate (CAGR) of 5.4% from 2023 to 2028.
Opportunities Abound in Pain Management
Pain management drugs and devices play a crucial role in alleviating pain and improving the quality of life for individuals worldwide. As chronic conditions become more prevalent, especially among the aging population, the demand for effective pain management solutions is on the rise. Additionally, advancements in medical technology have led to the development of minimally invasive and highly efficient pain management devices, reducing patient recovery times significantly.
Insights into Market Trends
The report provides valuable insights into the emerging trends in the pain management drugs and devices market. It covers an array of topics, including the assessment of technology advances in opioid and non-narcotic drugs, which have revolutionized pain management by offering practical alternatives to traditional opioids. The market report also examines the factors driving industry growth, including market opportunities and challenges, product categories, clinical trials, regulatory requirements, and patent analysis.
Global Market Segmentation
The global pain management drugs and devices market is segmented by product, application, and region:
Product Segmentation:
- Pharmaceuticals
- Narcotic Drugs
- Non-narcotic Drugs
- Antimigraine Drugs
- Anesthesia Drugs
- Other Drugs
- Pain Management Devices
- Neurostimulation Devices
- Infusion Pumps
- Ablation Devices
Application Segmentation:
- Musculoskeletal Pain
- Post-operative Pain
- Neuropathic Pain
- Cancer Pain
- Migraine/Headache
- Other Applications (HIV/AIDS, Burn Pain, Dental Pain)
Region Segmentation:
- North America (U.S. and Canada)
- Europe (Germany, U.K., Italy, France, and Rest of Europe)
- Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific)
- Rest of the World
Leading Market Players
The report features comprehensive company profiles of key players in the pain management drugs and devices market, including:
- Abbott Laboratories
- AbbVie Inc
- Assertio Holdings Inc
- AstraZeneca
- Boston Scientific
- Eli Lilly
- Endo International
- Enovis
- GlaxoSmithKline
- Grunenthal
- Johnson & Johnson
- Medtronic
- Novartis International
- Vertex Pharmaceuticals
- Viatris
Growing Focus on ESG Development
The pain management drugs and devices industry is increasingly focusing on Environmental, Social, and Governance (ESG) development. The report includes an ESG perspective, covering key ESG issues, ranking, and consumer attitudes toward ESG in the market.
Emerging Technologies Shaping the Industry
Advancements in technology play a pivotal role in the pain management drugs and devices market. The report assesses technology advances in opioid drugs, non-narcotic drugs, neuromodulation devices, and infusion pumps. It also explores trends in pain management, including pharmacogenomics and AI-driven approaches.
Clinical Trials and Patent Analysis
The report provides an analysis of clinical trials, including the type of study, status, phase, region, and an overview of patent analysis. This section offers insights into the latest developments and innovations in pain management.
Competitive Intelligence
A comprehensive overview of the competitive landscape is presented in the report, encompassing both the pain management drugs and medical devices markets. It includes funding information and recent developments by key market players.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 171 |
| Forecast Period | 2023 – 2028 |
| Estimated Market Value (USD) in 2023 | $84.6 Billion |
| Forecasted Market Value (USD) by 2028 | $109.9 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/rlaaiy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Pain Management Drugs and Devices Market
